Cochlear | COH - Equity Capital And Reserves

Stock Price
250.17
Daily Change
-8.57 -3.31%
Monthly
-4.74%
Yearly
-19.25%
Q1 Forecast
263.64

Cochlear reported AUD1.95B in Equity Capital and Reserves for its fiscal semester ending in June of 2025.





Equity Capital And Reserves Change Date
Ansell USD 1.98B 72.5M Jun/2025
Avita Medical AUD -12.89M 17.39M Jun/2025
Cochlear AUD 1.95B 82.7M Jun/2025
CSL USD 21.41B 861M Jun/2025
Fisher Paykel Healthcare NZD 1.99B 95.8M Dec/2025
Healius AUD 1.03B 13.9M Dec/2024
Integral Diagnostics AUD 301.71M 1.33M Jun/2024
Mayne Pharma AUD 454.19M 93.58M Jun/2024
Mesoblast USD 597.44M 136.18M Jun/2025
Monash IVF AUD 250.42M 868K Jun/2025
Nanosonics AUD 209.91M 20.88M Jun/2025
Polynovo AUD 72.12M 3.07M Jun/2024
Ramsay Health Care AUD 5.71B 894M Jun/2025
Regis Healthcare AUD -16.72M 758K Jun/2025
ResMed USD 6.32B 199.62M Dec/2025
Sigma Healthcare AUD 4.67B 3.8B Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Telix Pharmaceuticals AUD 568.21M 164.24M Dec/2024